A systematic review of the present and future of non-alcoholic fatty liver disease
C Lucas, G Lucas, N Lucas… - Clinical and …, 2018 - termedia.pl
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the Western world. Ongoing research has furthered our understanding of NAFLD, the …
in the Western world. Ongoing research has furthered our understanding of NAFLD, the …
[HTML][HTML] The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD), a progressive liver disease that is
closely associated with obesity, type 2 diabetes, hypertension and dyslipidaemia, represents …
closely associated with obesity, type 2 diabetes, hypertension and dyslipidaemia, represents …
What's new in non-alcoholic fatty liver disease?
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease
worldwide, with an estimated prevalence of 25% in the Western World. NAFLD is a broad …
worldwide, with an estimated prevalence of 25% in the Western World. NAFLD is a broad …
[HTML][HTML] New therapeutic strategies in nonalcoholic fatty liver disease: A focus on promising drugs for nonalcoholic steatohepatitis
N Pydyn, K Miękus, J Jura, J Kotlinowski - Pharmacological Reports, 2020 - Springer
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide.
Globally, it is currently the most common liver disease and is estimated to affect up to 25% of …
Globally, it is currently the most common liver disease and is estimated to affect up to 25% of …
[PDF][PDF] Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease (NAFLD) and its progressive form non‐alcoholic
steatohepatitis (NASH), are rapidly becoming among the top causes of cirrhosis …
steatohepatitis (NASH), are rapidly becoming among the top causes of cirrhosis …
[HTML][HTML] Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?
B Baran, F Akyüz - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is an umbrella term to describe the entire
spectrum of this common liver disease. In patients with NAFLD, especially those with non …
spectrum of this common liver disease. In patients with NAFLD, especially those with non …
[HTML][HTML] Recent research trends and updates on nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD), together with metabolic syndrome and obesity,
has shown a rapid increase in prevalence worldwide and is emerging as a major cause of …
has shown a rapid increase in prevalence worldwide and is emerging as a major cause of …
Systematic review with meta‐analysis: non‐alcoholic steatohepatitis‐a case for personalised treatment based on pathogenic targets
ZM Younossi, MJ Reyes, A Mishra… - Alimentary …, 2014 - Wiley Online Library
Background Non‐alcoholic fatty liver disease (NAFLD) is an umbrella term, which
encompasses simple steatosis and non‐alcoholic steatohepatitis (NASH). The entire …
encompasses simple steatosis and non‐alcoholic steatohepatitis (NASH). The entire …
Epidemiology and natural history of patients with NAFLD
N Bhala, R Ibrahim Kamal Jouness… - Current …, 2013 - ingentaconnect.com
Non-alcoholic fatty liver disease (NAFLD) currently represents the most common liver
disease in Western countries, being found in 25-30% of the general population. NAFLD …
disease in Western countries, being found in 25-30% of the general population. NAFLD …
Present and future therapeutic strategies in non-alcoholic fatty liver disease
G Calamita, P Portincasa - Expert opinion on therapeutic targets, 2007 - Taylor & Francis
Non-alcoholic fatty liver disease (NAFLD) is found in individuals who do not drink or abuse
alcohol and represents a significant health burden for the general community. NAFLD is …
alcohol and represents a significant health burden for the general community. NAFLD is …